{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:42Z","timestamp":1790932182364,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":676,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK25759"],"award-info":[{"award-number":["DK25759"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P40-OD010939"],"award-info":[{"award-number":["P40-OD010939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/mt.2014.135","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T07:19:09Z","timestamp":1405495149000},"page":"2018-2027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Intrathecal Gene Therapy Corrects CNS Pathology in a Feline Model of Mucopolysaccharidosis I"],"prefix":"10.1016","volume":"22","author":[{"given":"Christian","family":"Hinderer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney L","family":"Gurda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Louboutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Ruane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.135_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1259\/bjr.20130467","article-title":"Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders","volume":"87","author":"Xing","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1038\/mt.2014.135_bib2","first-page":"223","article-title":"Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation","volume":"47","author":"Kachur","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1038\/mt.2014.135_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF02011954","article-title":"Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT\/MRI findings","volume":"23","author":"Taccone","year":"1993","journal-title":"Pediatr Radiol"},{"key":"10.1038\/mt.2014.135_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1651-2227.2005.tb02004.x","article-title":"Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I","volume":"94","author":"Vijay","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1038\/mt.2014.135_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3174\/ajnr.A2832","article-title":"Brain and spinal MR imaging findings in mucopolysaccharidoses: a review","volume":"34","author":"Zafeiriou","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1038\/mt.2014.135_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2010.11.022","article-title":"Cervical pachymeningeal hypertrophy as the initial and cardinal manifestation of mucopolysaccharidosis type I in monozygotic twins with a novel mutation in the alpha-L-iduronidase gene","volume":"302","author":"Furukawa","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1038\/mt.2014.135_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ymgme.2013.11.014","article-title":"Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the \u03b1-L-iduronidase gene in Hurler-Scheie syndrome","volume":"111","author":"Ahmed","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib8","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","article-title":"Mannose 6-phosphate receptors and lysosomal enzyme targeting","volume":"264","author":"Dahms","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2014.135_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/prep.1994.1035","article-title":"Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells","volume":"5","author":"Kakkis","year":"1994","journal-title":"Protein Expr Purif"},{"key":"10.1038\/mt.2014.135_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenboven","year":"2008","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1038\/mt.2014.135_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1600-0463.2011.02760.x","article-title":"Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase","volume":"119","author":"Chen","year":"2011","journal-title":"APMIS"},{"key":"10.1038\/mt.2014.135_bib12","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ymgme.2009.10.053","article-title":"Intrathecal enzyme replacement therapy treats meningeal storage and spinal cord compression in MPS I dogs","volume":"99","author":"Dickson","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib13","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ymgme.2007.10.034","article-title":"Initial experience with intrathecal recombinant human alpha-L-iduronidase for spinal cord compression in two mucopolysaccharidosis I patients","volume":"93","author":"Dickson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib14","first-page":"70","article-title":"Intrathecal enzyme replacement therapy may stabilize or reverse signs of spinal cord compression in MPS I dogs","volume":"98","author":"Dickson","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2010.06.020","article-title":"Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I","volume":"101","author":"Dickson","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2007.10.034","article-title":"Intrathecal recombinant human a-L-iduronidase alleviates spinal cord compression symptoms and is well-tolerated in attenuated MPS I patients","volume":"93","author":"Dickson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib18","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"Munoz-Rojas","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1038\/mt.2014.135_bib19","first-page":"482","article-title":"Clinical trials in neurological disorders using AAV vectors: promises and challenges","volume":"6","author":"Mandel","year":"2004","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2014.135_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jgm.885","article-title":"Immune responses to AAV in a phase I study for Canavan disease","volume":"8","author":"McPhee","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2014.135_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/hum.2011.220","article-title":"Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease","volume":"23","author":"Mittermeyer","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2014.135_bib22","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/mt.2014.135_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2011.02.015","article-title":"Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I","volume":"43","author":"Wolf","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2014.135_bib24","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1172\/JCI66778","article-title":"Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy","volume":"123","author":"Haurigot","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2014.135_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.20392","article-title":"Effective gene therapy for an inherited CNS disease in a large animal model","volume":"57","author":"Vite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2014.135_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20870","article-title":"Gene therapy of the brain in the dog model of Hurler's syndrome","volume":"60","author":"Ciron","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2014.135_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.135_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/gt.2014.16","article-title":"Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats","volume":"21","author":"Bucher","year":"2014","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.135_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2011.03.011","article-title":"Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations","volume":"103","author":"Vite","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/mgme.1999.2860","article-title":"Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats","volume":"67","author":"He","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1038\/mt.2014.135_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-010-9254-8","article-title":"Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases","volume":"34","author":"Langford-Smith","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2014.135_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"Randall","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib34","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S1525-0016(16)34929-2","article-title":"Immune response activation and neurotoxicity after intrathecal infusion of AAV9 vector encoding a non-self reporter protein in the non-human primate","volume":"21","author":"Samaranch","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.135_bib35","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2014.135_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymgme.2012.02.003","article-title":"Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"106","author":"Dickson","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2014.135_bib37","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/mt.2014.135_bib38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/hum.2011.031","article-title":"Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors","volume":"22","author":"Wang","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2014.135_bib39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10719-008-9137-5","article-title":"Hexosaminidase assays","volume":"26","author":"Wendeler","year":"2009","journal-title":"Glycoconj J"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:56:57Z","timestamp":1771606617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616302507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1525001616302507"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.135","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal Gene Therapy Corrects CNS Pathology in a Feline Model of Mucopolysaccharidosis I","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2014.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}